Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hong Kong | 10 | 2024 | 27 | 1.200 |
Why?
|
Drug Design | 1 | 2023 | 162 | 0.820 |
Why?
|
Breast Neoplasms | 3 | 2018 | 1502 | 0.790 |
Why?
|
Smoking Cessation | 3 | 2024 | 517 | 0.760 |
Why?
|
Proteins | 1 | 2023 | 369 | 0.740 |
Why?
|
Hot Temperature | 2 | 2024 | 128 | 0.700 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 803 | 0.680 |
Why?
|
Neoplasms | 3 | 2022 | 1103 | 0.670 |
Why?
|
Awareness | 1 | 2019 | 65 | 0.660 |
Why?
|
Intention | 1 | 2019 | 94 | 0.640 |
Why?
|
Curcumin | 1 | 2018 | 74 | 0.600 |
Why?
|
Smad4 Protein | 1 | 2017 | 7 | 0.580 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 42 | 0.580 |
Why?
|
Glucose | 1 | 2018 | 230 | 0.570 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2017 | 52 | 0.550 |
Why?
|
Lactic Acid | 1 | 2016 | 95 | 0.550 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 433 | 0.550 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 197 | 0.510 |
Why?
|
Glycolysis | 1 | 2015 | 68 | 0.500 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 58 | 0.500 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 122 | 0.490 |
Why?
|
Lung Neoplasms | 1 | 2017 | 358 | 0.420 |
Why?
|
Inflammation | 1 | 2017 | 618 | 0.420 |
Why?
|
Humans | 19 | 2024 | 37093 | 0.400 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 485 | 0.390 |
Why?
|
Female | 11 | 2024 | 20969 | 0.370 |
Why?
|
Mental Health | 2 | 2024 | 303 | 0.360 |
Why?
|
Phosphorylation | 3 | 2018 | 928 | 0.350 |
Why?
|
Breath Tests | 2 | 2024 | 24 | 0.290 |
Why?
|
Carbon Monoxide | 2 | 2024 | 34 | 0.290 |
Why?
|
Middle Aged | 5 | 2024 | 10129 | 0.280 |
Why?
|
Male | 8 | 2024 | 20025 | 0.270 |
Why?
|
Cell Line, Tumor | 3 | 2018 | 2231 | 0.270 |
Why?
|
Ligands | 2 | 2023 | 349 | 0.250 |
Why?
|
Disease Progression | 2 | 2018 | 601 | 0.250 |
Why?
|
NF-kappa B | 2 | 2018 | 339 | 0.250 |
Why?
|
Adult | 8 | 2024 | 11712 | 0.250 |
Why?
|
Cotinine | 1 | 2024 | 43 | 0.240 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 2721 | 0.230 |
Why?
|
Saliva | 1 | 2024 | 107 | 0.220 |
Why?
|
Animals | 5 | 2022 | 15081 | 0.200 |
Why?
|
Commerce | 1 | 2022 | 87 | 0.200 |
Why?
|
Molecular Structure | 1 | 2023 | 492 | 0.200 |
Why?
|
Fathers | 1 | 2021 | 33 | 0.200 |
Why?
|
Tobacco Use Cessation | 1 | 2021 | 16 | 0.190 |
Why?
|
Cell Proliferation | 2 | 2017 | 1198 | 0.180 |
Why?
|
Exosomes | 1 | 2022 | 101 | 0.180 |
Why?
|
Behavior Therapy | 1 | 2021 | 167 | 0.180 |
Why?
|
Interpersonal Relations | 1 | 2021 | 205 | 0.170 |
Why?
|
Signal Transduction | 3 | 2017 | 1908 | 0.170 |
Why?
|
Apoptosis | 2 | 2017 | 1398 | 0.170 |
Why?
|
Young Adult | 4 | 2024 | 4268 | 0.170 |
Why?
|
Aerosols | 1 | 2019 | 48 | 0.170 |
Why?
|
Acetylation | 1 | 2018 | 98 | 0.160 |
Why?
|
Hyperglycemia | 1 | 2018 | 55 | 0.150 |
Why?
|
Withanolides | 1 | 2017 | 9 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 259 | 0.150 |
Why?
|
STAT1 Transcription Factor | 1 | 2017 | 35 | 0.150 |
Why?
|
Social Class | 1 | 2019 | 247 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2016 | 17 | 0.150 |
Why?
|
Telomerase | 1 | 2017 | 44 | 0.140 |
Why?
|
Ubiquitination | 1 | 2017 | 61 | 0.140 |
Why?
|
Mice | 2 | 2018 | 5913 | 0.140 |
Why?
|
Interleukin-6 | 1 | 2017 | 153 | 0.140 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 90 | 0.140 |
Why?
|
Diabetes Complications | 1 | 2016 | 90 | 0.140 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2018 | 213 | 0.140 |
Why?
|
Mice, Nude | 1 | 2017 | 337 | 0.130 |
Why?
|
Adolescent | 3 | 2024 | 5363 | 0.130 |
Why?
|
Age Factors | 1 | 2019 | 1033 | 0.130 |
Why?
|
Health Status | 1 | 2019 | 380 | 0.130 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 502 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 461 | 0.130 |
Why?
|
Neoplasm Metastasis | 1 | 2016 | 219 | 0.130 |
Why?
|
Deoxyglucose | 1 | 2015 | 19 | 0.130 |
Why?
|
Intracellular Space | 1 | 2015 | 35 | 0.130 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 356 | 0.130 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 54 | 0.130 |
Why?
|
Insulin Resistance | 1 | 2016 | 184 | 0.120 |
Why?
|
Models, Molecular | 1 | 2018 | 808 | 0.120 |
Why?
|
Adenosine Triphosphate | 1 | 2015 | 196 | 0.120 |
Why?
|
Receptors, Estrogen | 1 | 2015 | 156 | 0.120 |
Why?
|
Phenotype | 1 | 2016 | 689 | 0.120 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 146 | 0.120 |
Why?
|
Cell Movement | 1 | 2017 | 571 | 0.110 |
Why?
|
Carrier Proteins | 1 | 2015 | 305 | 0.110 |
Why?
|
Disease Models, Animal | 1 | 2018 | 1371 | 0.110 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 1039 | 0.100 |
Why?
|
Cell Survival | 1 | 2015 | 864 | 0.100 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 441 | 0.100 |
Why?
|
Aged | 2 | 2024 | 6741 | 0.100 |
Why?
|
Obesity | 1 | 2017 | 1067 | 0.080 |
Why?
|
Alcohol Drinking | 2 | 2024 | 519 | 0.080 |
Why?
|
Exhalation | 1 | 2024 | 10 | 0.060 |
Why?
|
Singapore | 1 | 2024 | 14 | 0.060 |
Why?
|
China | 1 | 2024 | 196 | 0.060 |
Why?
|
Linear Models | 1 | 2023 | 275 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2023 | 155 | 0.050 |
Why?
|
Family Health | 1 | 2021 | 56 | 0.050 |
Why?
|
Prenatal Care | 1 | 2021 | 73 | 0.050 |
Why?
|
Universities | 1 | 2024 | 442 | 0.050 |
Why?
|
Adaptation, Psychological | 1 | 2023 | 385 | 0.050 |
Why?
|
Students | 1 | 2024 | 519 | 0.040 |
Why?
|
Communication | 1 | 2020 | 180 | 0.040 |
Why?
|
Models, Biological | 1 | 2022 | 677 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 45 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 76 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2017 | 131 | 0.040 |
Why?
|
MicroRNAs | 1 | 2022 | 426 | 0.030 |
Why?
|
Prospective Studies | 1 | 2020 | 1378 | 0.030 |
Why?
|
Pregnancy | 1 | 2021 | 1549 | 0.030 |
Why?
|
Blotting, Western | 1 | 2017 | 859 | 0.030 |
Why?
|
United States | 1 | 2024 | 4223 | 0.030 |
Why?
|